Literature DB >> 9512898

IL-6 and IL-8 production by human bone marrow stromal cells.

F Rougier1, E Cornu, V Praloran, Y Denizot.   

Abstract

By using a specific enzyme-linked immunosorbent assay, the authors demonstrated that human bone marrow stromal cells produce IL-6 and IL-8. Their synthesis is enhanced in a dose-dependent manner after stimulation with lipopolysaccharide (LPS) and phorbol myristate acetate (PMA). Interleukin 6 (IL-6) and IL-8 production in response to PMA were markedly diminished by the PKC inhibitor staurosporine. IL-6 (10 ng/ml) stimulated IL-8 production with 0% and 10% fetal calf serum (FCS) in the culture medium. In similar conditions, IL-8 (10 ng/ml) enhanced IL-6 production. IL-1 alpha, IL-1 beta, and IL-3, tumour necrosis factor alpha (TNF-alpha), Stem cell factor (SCF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (at 10 ng/ml) stimulated IL-6 and IL-8 production in 0% and 10% FCS. G-CSF stimulated and IL-4 inhibited IL-8 production in 10% FCS. IL-2, IL-4 and bFGF stimulated IL-6 production in 0% FCS. These results suggest that bone marrow stromal cells might represent a major source for the cytokine-regulated local production of IL-6 and IL-8 inside human bone marrow.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512898     DOI: 10.1006/cyto.1997.0262

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.

Authors:  Michal Bar-Natan; Dina Stroopinsky; Katarina Luptakova; Maxwell D Coll; Arie Apel; Hasan Rajabi; Athalia R Pyzer; Kristen Palmer; Michaela R Reagan; Myrna R Nahas; Rebecca Karp Leaf; Salvia Jain; Jon Arnason; Irene M Ghobrial; Kenneth C Anderson; Donald Kufe; Jacalyn Rosenblatt; David Avigan
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

2.  Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion.

Authors:  Mandana Haack-Sørensen; Susanne Kofoed Hansen; Louise Hansen; Michael Gaster; Poul Hyttel; Annette Ekblond; Jens Kastrup
Journal:  Stem Cell Rev Rep       Date:  2013-02       Impact factor: 5.739

3.  Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasms.

Authors:  Julius Wehrle; Thalia S Seeger; Sven Schwemmers; Dietmar Pfeifer; Alla Bulashevska; Heike L Pahl
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

4.  Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.

Authors:  Takafumi Nakao; Shokei Kim; Kensuke Ohta; Hitomi Kawano; Masayuki Hino; Katsuyuki Miura; Noriyuki Tatsumi; Hiroshi Iwao
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

5.  Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism.

Authors:  Katie L Pricola; Nastaran Z Kuhn; Hana Haleem-Smith; Yingjie Song; Rocky S Tuan
Journal:  J Cell Biochem       Date:  2009-10-15       Impact factor: 4.429

6.  Comparison of vascular complications between conventional treatment and bone marrow transplantation for children with beta-thalassemia disease.

Authors:  Alisa Limsuwan; Darin Tubtom; Samart Pakakasama; Ampiwan Chaunsumrit
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

7.  Deriving a Boolean dynamics to reveal macrophage activation with in vitro temporal cytokine expression profiles.

Authors:  Ricardo Ramirez; Allen Michael Herrera; Joshua Ramirez; Chunjiang Qian; David W Melton; Paula K Shireman; Yu-Fang Jin
Journal:  BMC Bioinformatics       Date:  2019-12-18       Impact factor: 3.169

8.  The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.

Authors:  Marcel Spaargaren; Zemin Ren; Hildo Lantermans; Annemieke Kuil; Willem Kraan; Fernando Arenzana-Seisdedos; Marie José Kersten; Steven T Pals
Journal:  J Hematol Oncol       Date:  2021-01-12       Impact factor: 17.388

9.  Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study.

Authors:  Brenda A Jensen; Rebecca J Leeman; Jennifer J Schlezinger; David H Sherr
Journal:  Environ Health       Date:  2003-12-16       Impact factor: 5.984

10.  Production of hemo- and immunoregulatory cytokines by erythroblast antigen+ and glycophorin A+ cells from human bone marrow.

Authors:  Sergey V Sennikov; Tatyana V Injelevskaya; Sergey V Krysov; Alexandr N Silkov; Igor B Kovinev; Natalya J Dyachkova; Anton N Zenkov; Mary I Loseva; Vladimir A Kozlov
Journal:  BMC Cell Biol       Date:  2004-10-18       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.